Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $395.14 | 14 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Endo Pharmaceuticals Inc. | $135.51 | 2 | $0 (2023) |
| GlaxoSmithKline, LLC. | $93.89 | 3 | $0 (2017) |
| ABBVIE INC. | $32.88 | 1 | $0 (2024) |
| Stryker Corporation | $31.56 | 1 | $0 (2024) |
| Bioventus LLC | $17.06 | 1 | $0 (2024) |
| Lilly USA, LLC | $16.98 | 1 | $0 (2017) |
| Orthofix Medical, Inc. | $15.27 | 1 | $0 (2024) |
| PFIZER INC. | $14.02 | 1 | $0 (2017) |
| Endo USA, Inc. | $13.85 | 1 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $12.19 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $110.62 | 5 | ABBVIE INC. ($32.88) |
| 2023 | $135.51 | 2 | Endo Pharmaceuticals Inc. ($135.51) |
| 2017 | $149.01 | 7 | GlaxoSmithKline, LLC. ($93.89) |
All Payment Transactions
14 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/19/2024 | Endo USA, Inc. | XIAFLEX (Biological) | Food and Beverage | In-kind items and services | $13.85 | General |
| Category: ORTHOPEDIC | ||||||
| 06/12/2024 | ABBVIE INC. | DALVANCE (Drug), TEFLARO | Food and Beverage | In-kind items and services | $32.88 | General |
| Category: ANTI-INFECTIVE | ||||||
| 03/11/2024 | Orthofix Medical, Inc. | Physio-Stim (Device) | Food and Beverage | In-kind items and services | $15.27 | General |
| Category: Stimulator, Bone Growth, Non-Invasive | ||||||
| 03/06/2024 | Bioventus LLC | DUROLANE (Device) | Food and Beverage | In-kind items and services | $17.06 | General |
| Category: ORTHOPEDICSORTHOPEDIC SURGERY | ||||||
| 02/28/2024 | Stryker Corporation | MAKO (Device) | Food and Beverage | In-kind items and services | $31.56 | General |
| Category: KNEES, HIPS | ||||||
| 11/02/2023 | Endo Pharmaceuticals Inc. | XIAFLEX (Biological) | Food and Beverage | In-kind items and services | $129.15 | General |
| Category: ORTHOPEDIC | ||||||
| 06/06/2023 | Endo Pharmaceuticals Inc. | XIAFLEX (Biological) | Food and Beverage | In-kind items and services | $6.36 | General |
| Category: ORTHOPEDIC | ||||||
| 09/07/2017 | SANOFI-AVENTIS U.S. LLC | SOLIQUA (Drug) | Food and Beverage | In-kind items and services | $12.19 | General |
| Category: DIABETES | ||||||
| 08/10/2017 | PFIZER INC. | PREVNAR - 13 (Biological), TRUMENBA | Food and Beverage | In-kind items and services | $14.02 | General |
| Category: VACCINES | ||||||
| 07/31/2017 | GlaxoSmithKline, LLC. | BEXSERO (Biological) | Food and Beverage | In-kind items and services | $65.93 | General |
| Category: VACCINES | ||||||
| 07/20/2017 | Lilly USA, LLC | TRULICITY (Drug), BASAGLAR | Food and Beverage | In-kind items and services | $16.98 | General |
| Category: Diabetes | ||||||
| 07/12/2017 | GlaxoSmithKline, LLC. | BREO (Drug) | Food and Beverage | In-kind items and services | $12.59 | General |
| Category: RESPIRATORY | ||||||
| 04/20/2017 | Merck Sharp & Dohme Corporation | ZOSTAVAX (Biological), PNEUMOVAX 23, GARDASIL9 | Food and Beverage | In-kind items and services | $11.93 | General |
| Category: VACCINE | ||||||
| 03/27/2017 | GlaxoSmithKline, LLC. | BREO (Drug) | Food and Beverage | In-kind items and services | $15.37 | General |
| Category: RESPIRATORY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 160 | 323 | $37,213 | $14,233 |
| 2022 | 6 | 173 | 435 | $42,345 | $17,383 |
| 2021 | 8 | 230 | 428 | $48,835 | $20,509 |
| 2020 | 7 | 255 | 421 | $46,370 | $16,320 |
All Medicare Procedures & Services
26 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 56 | 90 | $19,520 | $7,932 | 40.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 28 | 28 | $8,672 | $2,995 | 34.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 37 | 46 | $7,580 | $2,901 | 38.3% |
| 73030 | X-ray of shoulder, minimum of 2 views | Office | 2023 | 11 | 12 | $1,000 | $278.96 | 27.9% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 28 | 147 | $441.00 | $126.12 | 28.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 57 | 119 | $22,372 | $10,303 | 46.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 26 | 26 | $7,514 | $2,741 | 36.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 24 | 32 | $4,600 | $2,048 | 44.5% |
| 20611 | Aspiration and/or injection of fluid large joint using ultrasound guidance | Office | 2022 | 19 | 22 | $4,536 | $1,482 | 32.7% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2022 | 11 | 12 | $2,651 | $612.85 | 23.1% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2022 | 36 | 224 | $672.00 | $196.77 | 29.3% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 54 | 96 | $18,048 | $8,428 | 46.7% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 30 | 30 | $8,670 | $3,390 | 39.1% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 34 | 50 | $6,400 | $3,349 | 52.3% |
| 20611 | Aspiration and/or injection of major joint or joint capsule with recording and reporting using ultrasound guidance | Office | 2021 | 24 | 29 | $5,421 | $2,122 | 39.1% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 28 | 28 | $5,320 | $2,103 | 39.5% |
| 73564 | X-ray of knee, 4 or more views | Office | 2021 | 14 | 17 | $1,530 | $523.62 | 34.2% |
| 20610 | Aspiration and/or injection of large joint or joint capsule | Office | 2021 | 11 | 14 | $2,954 | $430.74 | 14.6% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2021 | 35 | 164 | $492.00 | $163.62 | 33.3% |
| 99203 | New patient office or other outpatient visit, typically 30 minutes | Office | 2020 | 89 | 89 | $16,910 | $6,062 | 35.9% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 48 | 76 | $9,728 | $3,743 | 38.5% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 32 | 47 | $8,836 | $3,643 | 41.2% |
| 20610 | Aspiration and/or injection of large joint or joint capsule | Office | 2020 | 24 | 31 | $6,753 | $1,488 | 22.0% |
| 73564 | X-ray of knee, 4 or more views | Office | 2020 | 18 | 23 | $2,070 | $687.39 | 33.2% |
| 73030 | X-ray of shoulder, minimum of 2 views | Office | 2020 | 16 | 24 | $1,680 | $543.57 | 32.4% |
About Dr. Nicholas Defauw, DO
Dr. Nicholas Defauw, DO is a Sports Medicine healthcare provider based in Goshen, Indiana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/01/2009. The National Provider Identifier (NPI) number assigned to this provider is 1578791398.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Nicholas Defauw, DO has received a total of $395.14 in payments from pharmaceutical and medical device companies, with $110.62 received in 2024. These payments were reported across 14 transactions from 11 companies. The most common payment nature is "Food and Beverage" ($395.14).
As a Medicare-enrolled provider, Defauw has provided services to 818 Medicare beneficiaries, totaling 1,607 services with total Medicare billing of $68,445. Data is available for 4 years (2020–2023), covering 26 distinct procedure/service records.
Practice Information
- Specialty Sports Medicine
- Location Goshen, IN
- Active Since 07/01/2009
- Last Updated 03/18/2024
- Taxonomy Code 207QS0010X
- Entity Type Individual
- NPI Number 1578791398
Products in Payments
- XIAFLEX (Biological) $149.36
- BEXSERO (Biological) $65.93
- DALVANCE (Drug) $32.88
- MAKO (Device) $31.56
- BREO (Drug) $27.96
- DUROLANE (Device) $17.06
- TRULICITY (Drug) $16.98
- Physio-Stim (Device) $15.27
- PREVNAR - 13 (Biological) $14.02
- SOLIQUA (Drug) $12.19
- ZOSTAVAX (Biological) $11.93
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.